| 摘要 |
PROBLEM TO BE SOLVED: To obtain the subject relapse suppressant for cancer capable of manifesting suppressant effects on hepatocellular carcinoma relapse or hepatocellular carcinogenesis and effectively used for the suppression, etc., of the relapse after the radical treatment of hepatocellular carcinoma C by using interferon-βas an active ingredient. SOLUTION: This suppressant for the relapse of hepatocellular carcinoma C obtained by using interferon-βas an active ingredient and, as necessary, adding human serum albumin, a polyol, an organic acid buffer, etc., as a stabilizer thereto and formulating the interferon-βas dosage forms of various states such as a parenteral injection, a capsule, a nasal drop, a suppository, an oral agent or an ointment. The resultant suppressant has suppressing effects on the relapse after the radical treatment of hepatocellular carcinoma C such as surgical excision, percutaneous ethanol injection therapy(PEIT), percutaneous microwave coagulation therapy(PMCT), transcatheter arterial embolization(TAE) or repeated transarterial anticancer drug infusion therapy(TAI).
|
